News &

Press

venBio news

“venBio Raises $550 Million Venture Capital Fund Focused on Life Sciences.”

“venBio Closes $394 Million Life Sciences Venture Capital Fund.”

Portfolio news

Harmony Biosciences Receives FDA Approval For Expanded Use Of WAKIX® (pitolisant) For The Treatment Of Cataplexy In Adult Patients With Narcolepsy

Oct 14, 2020

RayzeBio Launches with $45 Million Series A to Advance Portfolio of Targeted Radiopharmaceuticals for Cancer Therapeutics

Oct 14, 2020

Metacrine Announces Pricing of Initial Public Offering

Sep 15, 2020

Attralus Launches with $25 Million Series A Financing from venBio Partners to Transform Treatment for Patients with Systemic Amyloidosis

Sep 14, 2020

Harmony Biosciences Announces Pricing Of Upsized Initial Public Offering

Aug 18, 2020

Checkmate Pharmaceuticals Announces Pricing of Initial Public Offering

Aug 6, 2020

ALX Oncology Announces Pricing of Initial Public Offering

Jul 16, 2020

San Francisco office

1700 Owens Street, Suite 595
San Francisco, CA 94158

Seattle office

1200 Westlake Ave N, Suite 900
Seattle, WA 98109

© 2023 venBio. All Rights Reserved.